Year of investment: 2012

BioActor develops and markets proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements.

BioActor focuses on the development of proprietary bioactives with human clinical evidence that address health concerns related to metabolic syndrome and ageing such as diabetes, osteoporosis and cardiovascular disease.